Medical Condition News

RSS

Ninth annual Tour DaVita bike event to be held in NC to raise awareness on kidney disease

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, announces North Carolina as the host of the ninth annual Tour DaVita bike event.

15 Sep 2015

Cardiovascular disease morbidity is significantly reduced through intensive management of blood pressure

According to initial results of a multi-site landmark study, led by Dominic Raj, M.D., at the George Washington University (GW) site, cardiovascular disease morbidity is significantly reduced through intensive management of high blood pressure.

15 Sep 2015

Study shows link between impaired mitochondria, energy failure, and neuronal dysfunction

A new study from the Gladstone Institutes shows for the first time that impairments in mitochondria--the brain's cellular power plants--can deplete cellular energy levels and cause neuronal dysfunction in a model of neurodegenerative disease.

15 Sep 2015

Cautiously-designed combination therapies may attenuate side effects associated with Alzheimer's drugs

BACE1 is the major drug target for Alzheimer's disease, but we know surprisingly little about its normal function in the CNS.

15 Sep 2015

Three studies point to mGluR2 as new molecular target for addiction treatment

The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.

15 Sep 2015

UCI researchers uncover new underlying factor of seizures

University of California, Irvine researchers with the School of Medicine have identified the mechanism by which valproic acid controls epileptic seizures, and by doing so, also revealed an underlying factor of seizures.

15 Sep 2015

UT Southwestern evaluates allopurinol drug to prevent nephropathy in Type I diabetes patients

UT Southwestern Medical Center has joined an international clinical trial studying whether a drug traditionally used to treat gout can help prevent kidney damage in patients with Type 1 diabetes.

15 Sep 2015

Study reveals how leukemia cells evade deadly effects of BRD4 inhibitors

BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials.

15 Sep 2015

EORTC trial evaluates effectiveness of pembrolizumab in patients with high-risk stage III melanoma

A recently opened double- blind phase III EORTC trial 1325 will prospectively assess whether post-operative adjuvant therapy with pembrolizumab, an anti-PD-1 monoclonal antibody, improves recurrence-free survival as compared to placebo in patients with high-risk stage III melanoma.

15 Sep 2015

Air pollution from forest fires aggravates children’s respiratory health

Research coordinated by lecturer of the Faculty of Nursing at the University of Valencia Ferran Ballester has shown that air pollution from forest fires aggravates the respiratory health of children.

15 Sep 2015

$Whole-genome sequencing identifies EN1 gene as determinant of bone mineral density, fracture$

Whole-genome sequencing identifies EN1 gene as determinant of bone mineral density, fracture

Using extensive genetic data compiled by the UK10K project, an international team of researchers led by Dr. Brent Richards of the Lady Davis Institute at the Jewish General Hospital has identified a genetic variant near the gene EN1 as having the strongest effect on bone mineral density (BMD) and fracture identified to date.

15 Sep 2015

Molecular biology research holds promise in understanding cancer growth, aging

Researchers at the Johns Hopkins University have found molecular evidence of how a biochemical process controls the lengths of protective chromosome tips, a potentially significant step in ultimately understanding cancer growth and aging.

15 Sep 2015

EORTC and ESSO project provides opportunity to do prospective study on liver metastasis surgery

Is it possible to cure patients with unresectable colorectal liver metastases? Are complex surgeries safe for patients with extensive metastatic disease? How can we monitor and improve the quality of these surgical strategies? How can we improve surgical care for patients through research?

15 Sep 2015

BfArM approves Greenovation’s moss-aGal phase I clinical trial for Fabry disease

Greenovation Biotech GmbH announced today that it has received approval to begin a phase I clinical trial in Europe for its first drug candidate moss-aGal (agalsidase) from Germany's regulatory authority, the Federal Institute for Drugs and Medical Devices (BfArM).

15 Sep 2015

Sun Biomedical begins DMX-200 Phase II trial for treatment of chronic kidney disease

Sun Biomedical Limited today announced the first patient had been enrolled in a Phase II study of DMX-200, an innovative new treatment that combines two different drugs to treat chronic kidney disease.

15 Sep 2015

Prolonged sitting time, reduced physical activity contribute to non-alcoholic fatty liver disease

Prolonged sitting time as well as reduced physical activity contribute to the prevalence of non-alcoholic fatty liver disease (NAFLD) in a study of middle-aged Koreans.

15 Sep 2015

Researchers show how a cell surface protein can mobilize immune cells to attack malignant tumors

Revealing a biological combat strategy worthy of a five-star general, researchers from Houston Methodist Hospital, University of Chicago and Cornell University have shown how a cell surface receptor--a specialized protein which communicates signals between a cell and the outside world--can mobilize immune cells to attack, rather than protect, malignant tumors.

15 Sep 2015

Regular smokers at increased risk of tooth loss, new study confirms

A new study has confirmed that regular smokers have a significantly increased risk of tooth loss. Male smokers are up to 3.6 times more likely to lose their teeth than non-smokers, whereas female smokers were found to be 2.5 times more likely.

15 Sep 2015

Inhibition of FGFR3 receptor could be a new way of treating patients with liver cell cancer

In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.

15 Sep 2015

Air pollution linked to overall increase in risk of death

In what is believed to be the largest, most detailed study of its kind in the United States, scientists at NYU Langone Medical Center and elsewhere have confirmed that tiny chemical particles in the air we breathe are linked to an overall increase in risk of death.

15 Sep 2015

Medical Condition News

Ninth annual Tour DaVita bike event to be held in NC to raise awareness on kidney disease

Cardiovascular disease morbidity is significantly reduced through intensive management of blood pressure

Study shows link between impaired mitochondria, energy failure, and neuronal dysfunction

Cautiously-designed combination therapies may attenuate side effects associated with Alzheimer's drugs

Three studies point to mGluR2 as new molecular target for addiction treatment

UCI researchers uncover new underlying factor of seizures

UT Southwestern evaluates allopurinol drug to prevent nephropathy in Type I diabetes patients

Study reveals how leukemia cells evade deadly effects of BRD4 inhibitors

EORTC trial evaluates effectiveness of pembrolizumab in patients with high-risk stage III melanoma

Air pollution from forest fires aggravates children’s respiratory health

Whole-genome sequencing identifies EN1 gene as determinant of bone mineral density, fracture

Molecular biology research holds promise in understanding cancer growth, aging

EORTC and ESSO project provides opportunity to do prospective study on liver metastasis surgery

BfArM approves Greenovation’s moss-aGal phase I clinical trial for Fabry disease

Sun Biomedical begins DMX-200 Phase II trial for treatment of chronic kidney disease

Prolonged sitting time, reduced physical activity contribute to non-alcoholic fatty liver disease

Researchers show how a cell surface protein can mobilize immune cells to attack malignant tumors

Regular smokers at increased risk of tooth loss, new study confirms

Inhibition of FGFR3 receptor could be a new way of treating patients with liver cell cancer

Air pollution linked to overall increase in risk of death

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News